HomeATOS • NASDAQ
add
Atossa Therapeutics Inc
Previous close
$1.19
Day range
$1.17 - $1.23
Year range
$0.70 - $2.30
Market cap
153.42M USD
Avg Volume
634.93K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.38M | -14.50% |
Net income | -7.23M | -16.07% |
Net profit margin | — | — |
Earnings per share | -0.06 | -20.00% |
EBITDA | -6.38M | 14.52% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 74.77M | -20.49% |
Total assets | 79.48M | -21.85% |
Total liabilities | 5.80M | 68.29% |
Total equity | 73.68M | — |
Shares outstanding | 125.80M | — |
Price to book | 2.02 | — |
Return on assets | -19.31% | — |
Return on capital | -20.75% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -7.23M | -16.07% |
Cash from operations | -4.75M | -22.33% |
Cash from investing | -10.00K | -900.00% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -4.76M | 11.18% |
Free cash flow | -3.30M | -324.52% |
About
Founded
2008
Headquarters
Website
Employees
12
